Effect and safety of gemtuzumab ozogamicin for the treatment of patients with acute myeloid leukaemia: a systematic review protocol

INTRODUCTION: Acute myeloid leukaemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells or platelets. Gemtuzumab ozogamicin (GO) holds promise as a new agent that also could be efficacious in newly diagnosed AML with acceptabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhamad, Nor A, Mohd Dali, Nor S, Mohd Yacob, Aliza, Kassim, Mohd S A, Lodz, Noor A, Abdul Wahid, S F, Aris, Tahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299015/
https://www.ncbi.nlm.nih.gov/pubmed/32540885
http://dx.doi.org/10.1136/bmjopen-2019-032503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299015/
https://www.ncbi.nlm.nih.gov/pubmed/32540885
http://dx.doi.org/10.1136/bmjopen-2019-032503

Ejemplares similares